Literature DB >> 9199258

Comparison of arbutamine stress 99mTc-labeled sestamibi single-photon emission computed tomographic imaging and echocardiography for detection of the extent and severity of coronary artery disease and inducible ischemia.

R S Khattar1, R Senior, D Joseph, A Lahiri.   

Abstract

BACKGROUND: Arbutamine is a new synthetic catecholamine developed specifically for pharmacologic stress testing. METHODS AND
RESULTS: We investigated 39 patients undergoing coronary arteriography to compare arbutamine stress (99m)Tc-labeled sestamibi single-photon emission computed tomographic imaging and echocardiography for detection of the extent and severity of coronary artery disease and inducible ischemia. Rest and stress studies were analyzed blindly according to a 12-segment left ventricular model for both techniques. Each segment was graded according to severity of wall thickening abnormality and perfusion defect (1 = normal to 4 = severe). Total perfusion defect and wall thickening scores were calculated at peak stress and the difference in scores between stress and rest (delta perfusion defect; delta wall thickening) were used as indexes of inducible ischemia. Twenty-one patients had multivessel disease, nine had single-vessel disease, and nine had normal coronary arteries. Diagnostic accuracies for the detection of coronary artery disease for single-photon emission computed tomographic imaging and echocardiography were 95% and 92%, respectively. Extent and severity of coronary artery disease indicated by a peak stress perfusion defect score of 26 +/- 6.4 and wall thickening score of 25.1 +/- 8.4 were similar, and there was no significant difference in the delta perfusion defect and delta wall thickening scores of 8.7 +/- 5.5 and 10.4 +/- 7.1, respectively. Segmental concordance rates for the detection of coronary artery disease and inducible ischemia were 74% (K = 0.47; confidence interval 0.39 to 0.55) and 74% (kappa = 0.42; confidence interval 0.34 to 0.51), respectively. Regional concordance for coronary artery disease was 84% (kappa = 0.68; confidence interval 0.51 to 0.84). Where discordance was present, there was a greater prevalence of perfusion abnormality compared with wall thickening abnormality.
CONCLUSION: Arbutamine stress single-photon emission computed tomographic imaging and echocardiography provide largely equivalent and accurate pathophysiologic information for the evaluation of coronary artery disease and inducible ischemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199258     DOI: 10.1016/s1071-3581(97)90081-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  19 in total

1.  Synergistic value of simultaneous stress dobutamine sestamibi single-photon-emission computerized tomography and echocardiography in the detection of coronary artery disease.

Authors:  R Senior; B S Sridhara; E Anagnostou; C Handler; E B Raftery; A Lahiri
Journal:  Am Heart J       Date:  1994-10       Impact factor: 4.749

2.  Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiography.

Authors:  D S Segar; S E Brown; S G Sawada; T Ryan; H Feigenbaum
Journal:  J Am Coll Cardiol       Date:  1992-05       Impact factor: 24.094

3.  Stress testing with closed-loop arbutamine as an alternative to exercise. The International Arbutamine Study Group.

Authors:  C A Dennis; P E Pool; E J Perrins; S M Mohiuddin; J Sklar; W J Kostuk; D W Muller; M R Starling
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

4.  Arbutamine stress thallium-201 single-photon emission computed tomography using a computerized closed-loop delivery system. Multicenter trial for evaluation of safety and diagnostic accuracy. The International Arbutamine Study Group.

Authors:  H Kiat; A S Iskandrian; B J Villegas; M R Starling; D S Berman
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

5.  Simultaneous dobutamine stress echocardiography and technetium-99m isonitrile single-photon emission computed tomography in patients with suspected coronary artery disease.

Authors:  T Forster; A J McNeill; A Salustri; A E Reijs; E S el-Said; J R Roelandt; P M Fioretti
Journal:  J Am Coll Cardiol       Date:  1993-06       Impact factor: 24.094

6.  Dobutamine thallium myocardial perfusion tomography.

Authors:  D J Pennell; S R Underwood; R H Swanton; J M Walker; P J Ell
Journal:  J Am Coll Cardiol       Date:  1991-11-15       Impact factor: 24.094

7.  Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise.

Authors:  H G Stratmann; B R Tamesis; L T Younis; M D Wittry; D D Miller
Journal:  Am J Cardiol       Date:  1994-04-01       Impact factor: 2.778

8.  The comparative value of exercise echocardiography and 99m Tc MIBI single photon emission computed tomography in the diagnosis and localization of myocardial ischaemia.

Authors:  M M Pozzoli; A Salustri; G R Sutherland; B Tuccillo; J G Tijssen; J R Roelandt; P M Fioretti
Journal:  Eur Heart J       Date:  1991-12       Impact factor: 29.983

9.  Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography.

Authors:  T Marwick; B Willemart; A M D'Hondt; T Baudhuin; W Wijns; J M Detry; J Melin
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

10.  Dobutamine echocardiography and thallium-201 imaging predict functional improvement after revascularisation in severe ischaemic left ventricular dysfunction.

Authors:  R Senior; B Glenville; S Basu; B S Sridhara; E Anagnostou; R Stanbridge; S J Edmondson; C E Handler; E B Raftery; A Lahiri
Journal:  Br Heart J       Date:  1995-10
View more
  2 in total

Review 1.  Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease.

Authors:  N K Sabharwal; A Lahiri
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

2.  Prognostic validation of an algorithm to convert myocardial perfusion SPECT imaging data from a 12-segment model to a 17-segment model.

Authors:  Michael Salerno; Laine Elliot; Linda K Shaw; Jonathan P Piccini; Robert Pagnanelli; Salvador Borges-Neto
Journal:  J Nucl Cardiol       Date:  2009-06-03       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.